chartexchange

IMNM
Immunome, Inc.
stockNASDAQ

Market OpenNov 19, 2026 2:59:56 PM EST
16.58USD-1.222%(-0.20)414,447
Pre-marketNov 19, 2026 8:58:30 AM EST
16.80USD+0.119%(+0.02)
16.56Bid16.59Ask0.03Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Exton, PA, USA
Previous Close
$16.78
Beta
1.55
52-Week High
$30.06 2026-08-19
52-Week Low
$16.41 2026-10-16
SMA 50
$20.09
SMA 200
$22.08
Avg. Vol 10D
1.36M
Avg. Vol 30D
1.49M
Avg. Vol 90D
1.28M
Relative Vol
0.27
118.07M
108.28M
16,173,694
0.2800%
Mar 3, 2027 (104d)
IMNM Profile

immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. our unique and powerful immunotherapy discovery engine leverages "most highly educated" immune systems from patients who have already learned how to fight off their disease. this proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. we then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.

IMNM Performance
PeriodPriceDateChangeBeta
1W18.702026-11-12-11.06%3.196
1M16.772026-10-19-0.82%1.561
3M29.832026-08-19-44.23%1.605
6M19.662026-05-19-15.40%1.356
1Y17.692025-11-19-5.98%1.553
2Y9.392024-11-19+77.12%—
5Y17.202021-11-19-3.30%0.901
IMNM Stock Summary

Immunome, Inc. (NASDAQ:IMNM) stock price today is $16.63, and today's volume is 404,461. IMNM is down 0.883% today. The 30 day average volume is 1.49M. IMNM market cap is $1.96B with 118.07M shares outstanding.